Ricerca Launches Foresight With A Limited Time Offer

Monday, 26 July 2010

Ricerca Biosciences, LLC, is launching their new Foresight™ similarity analysis service on July 20. With Foresight, researchers can see into the future of compounds. It will allow them to compare their compound’s assay results against the assay results of a large reference set of pharmacologically active compounds. Specific benefits of Foresight include: Use of data from reliable tests to run on compounds Review annotations of similar compounds for insight into in vivo activity Gain an indication of potential adverse events Receive suggestions for steps to enhance the compound evaluation Fast on-demand results to accelerate decision making Foresight is the looking glass into the future. It allows a scientist to find clues to the possibilities of a compound, providing a resource for discovery and innovation. They can use it to direct compound modification to avoid adverse effects and determine new indications for safe and novel compounds.